Pterostilbene vs resveratrol: which polyphenol wins?

In the early 2000s, a single molecule carried almost the entire weight of longevity hype. Resveratrol — a polyphenol found in red wine, grape skins, and Japanese knotweed — was featured in a landmark 2006 Nature paper showing it extended the lifespan of overfed mice and activated SIRT1, a sirtuin enzyme linked to caloric restriction benefits. David Sinclair, the paper’s senior author, became the public face of longevity science. Resveratrol supplement sales exploded. Glasses of red wine acquired a scientific halo.

Two decades later, resveratrol’s reputation is more complicated. Human clinical trials have been mixed. The mechanism of SIRT1 activation turned out to be more nuanced than initially claimed. And perhaps most importantly, oral resveratrol turns out to have terrible bioavailability — most of what you swallow is either poorly absorbed or rapidly metabolized into compounds with uncertain activity.

Enter pterostilbene. It’s a chemical cousin of resveratrol, found in blueberries and the heartwood of the Indian kino tree, with two methyl groups replacing two hydroxyl groups on the resveratrol skeleton. That tiny structural change has a big practical consequence: pterostilbene is dramatically more bioavailable, more stable in the body, and in many assays more potent than its famous cousin. So which one should you actually take for longevity?

What you’ll learn:

The structural difference that makes pterostilbene more bioavailable
How both compounds activate sirtuins and other longevity pathways
Head-to-head evidence on cardiovascular, metabolic, and cognitive endpoints
Which is better supported for specific goals — and where the science is still thin

What are stilbenes?

Both compounds belong to a class called stilbenes — small polyphenolic molecules produced by plants as a defense response to fungal infection and UV stress. The parent stilbene has a simple two-ring structure connected by a two-carbon bridge.

Quick definition: Pterostilbene and resveratrol are stilbene polyphenols. Resveratrol is found in grape skins and red wine; pterostilbene is found in blueberries. Pterostilbene has higher oral bioavailability and longer half-life, while both activate sirtuins and AMPK, pathways central to cellular aging.

Structure and sources

Resveratrol (3,4’,5-trihydroxystilbene): two hydroxyl groups on one ring, one on the other. Found in red wine (~0.3-12 mg per glass), Japanese knotweed (the commercial extraction source), grape skins, peanuts, blueberries (in trace amounts).
Pterostilbene (3,5-dimethoxy-4’-hydroxystilbene): two methoxy groups instead of hydroxyl groups. Found primarily in blueberries (~100 μg per 100 g), Indian kino tree, and some grape varieties.

The two methoxy groups make pterostilbene significantly more lipophilic (fat-soluble), which has major consequences for how the body handles it.

Why bioavailability matters

Resveratrol’s biggest problem is that oral absorption is both low and rapid. After a typical oral dose, resveratrol is quickly absorbed but then just as quickly metabolized into glucuronides and sulfates in the gut and liver. The result: less than 1% of an oral resveratrol dose reaches the bloodstream as free resveratrol. Most pharmacokinetic studies show peak blood levels in the nanomolar range — well below the concentrations needed to activate SIRT1 in cell studies.

Pterostilbene, by contrast, has measured oral bioavailability of roughly 80% versus ~20% for resveratrol, with a longer half-life (~105 minutes vs ~14 minutes). For any given oral dose, pterostilbene reaches higher, longer-lasting tissue concentrations.

The science

Mechanisms (largely overlapping)

Both compounds activate several longevity-relevant pathways:

SIRT1 activation: both stilbenes activate the sirtuin family of NAD+-dependent deacetylases. SIRT1 regulates gene expression, inflammation, mitochondrial biogenesis, and metabolism. The mechanism turned out not to be direct activation but rather allosteric modulation via specific substrates.
AMPK activation: both activate AMP-activated protein kinase, the cellular “fuel gauge” that senses low energy. AMPK activation mimics effects of caloric restriction and exercise.
NF-κB inhibition: both suppress pro-inflammatory NF-κB signaling.
Antioxidant and mitochondrial effects: both reduce oxidative stress and improve mitochondrial function.
Glucose and lipid metabolism: both modestly improve insulin sensitivity and lipid profiles in animal studies.

Head-to-head differences

Potency: in some cell-based SIRT1 activation assays, pterostilbene is more potent than resveratrol, though direct comparisons are limited.
Anti-inflammatory effects: pterostilbene appears to be a stronger PPAR-α agonist and has shown greater effects on lipid metabolism in animal studies.
Memory and cognition: preclinical studies consistently show stronger memory-enhancing effects with pterostilbene.
Cardiovascular: both have shown benefits, but pterostilbene has more consistent effects on LDL cholesterol and blood pressure.

Human clinical evidence

Resveratrol trials:

Mixed results overall. Some benefit in insulin sensitivity and endothelial function in populations with metabolic disease. Little effect in metabolically healthy adults.
Doses used: 75-5000 mg/day. No clear dose-response.
A 2018 meta-analysis found small improvements in systolic blood pressure, fasting glucose, and inflammatory markers in specific populations.

Pterostilbene trials:

Blood pressure and lipids (2012): 80 adults with hyperlipidemia took 50-125 mg/day of pterostilbene for 6-8 weeks. Results showed modest blood pressure and LDL reductions. Higher doses produced larger effects on lipids but slightly raised LDL in some participants — a concerning signal.
Safety: generally well tolerated. Higher-dose studies have raised questions about lipid effects.
Cognitive function: limited direct trials in humans, though preclinical evidence is encouraging.

Stilbenes and biological aging

Stilbenes sit at the intersection of several core hallmarks of aging:

Nutrient sensing pathways: SIRT1 and AMPK are central to longevity regulation. Both stilbenes target this axis.
Mitochondrial dysfunction: both improve mitochondrial efficiency in preclinical models.
Chronic inflammation: both reduce inflammatory signaling.
Cellular senescence: some evidence both compounds have modest senomorphic activity.

The honest summary: stilbenes touch the right mechanisms, but the human clinical data — for both resveratrol and pterostilbene — falls short of dramatic longevity claims.

Head-to-head: which one and when

1. If prioritizing proven cardiovascular benefit, consider resveratrol

Resveratrol has more cardiovascular and metabolic clinical trial data simply because it’s been studied longer. In populations with insulin resistance or metabolic syndrome, modest benefits are reproducible.

2. If prioritizing bioavailability, pterostilbene wins

For any equivalent oral dose, pterostilbene reaches higher, more sustained blood levels. If you’re spending money on a stilbene supplement, more of it actually reaches your tissues with pterostilbene.

3. If targeting cognitive function, pterostilbene is mechanistically stronger

Preclinical data consistently shows stronger memory and cognitive effects with pterostilbene, though direct human cognition trials are limited.

4. If concerned about LDL cholesterol, use caution with high-dose pterostilbene

Some trials have shown that pterostilbene at the highest doses may slightly raise LDL in certain people. Monitor a lipid panel if supplementing long-term.

5. Don’t expect dramatic effects from either

Both compounds have shown modest benefits on specific biomarkers. Neither has convincingly demonstrated lifespan or biological age improvements in humans. Manage expectations accordingly.

6. Remember the food angle

A diet rich in blueberries, grapes, red wine in moderation, and other polyphenol-rich plants delivers a complex mix of stilbenes and related compounds that is arguably more valuable than any single isolated supplement. Food-based polyphenols are the consistent theme in long-lived populations. For a broader perspective on how different polyphenol classes work together, see our guide to polyphenols and biological aging.

The information provided does not replace professional medical advice. Consult your healthcare provider before starting any supplementation.

Dosing guidelines

Resveratrol:

Cardiovascular / metabolic support: 150-500 mg/day
Caloric restriction mimetic (theoretical): 500-1000 mg/day
Generally taken with a fat-containing meal for improved absorption

Pterostilbene:

General longevity / metabolic: 50-100 mg/day
Higher doses (150-250 mg/day) have been used but monitored for lipid changes

How to track stilbene effects

Metric	How to measure	Target direction
Blood pressure	Home monitor	Lower if elevated
LDL, HDL, triglycerides	Lipid panel	Improved profile
Fasting glucose, HbA1c	Blood test	Lower if elevated
hs-CRP	Blood test	Lower
VO2 max	Wearable	Stable or rising
Biological age	SuperAge, PhenoAge	Stable or declining

How SuperAge helps with polyphenol protocols

Polyphenol supplements are notoriously hard to evaluate subjectively. SuperAge makes the invisible visible:

Biological age trajectory

See whether your physiology is actually shifting over weeks and months — the only honest way to know whether an intervention is working.

Cardiovascular signals

Resting heart rate, HRV, and VO2 max are sensitive to cardiovascular and inflammatory changes that stilbenes theoretically target.

Recovery and sleep patterns

Inflammation and autonomic balance show up in sleep architecture and HRV. SuperAge tracks these continuously.

Frequently asked questions

Is resveratrol useless because of low bioavailability?

Not useless, but the effective tissue concentrations achieved orally are far below what cell studies suggest are needed. This is a real issue and is partly why pterostilbene has gained interest.

Can I just drink red wine?

A glass of red wine contains 0.3-12 mg of resveratrol — far below clinical trial doses. The health effects of moderate red wine consumption (if real) likely come from the overall polyphenol matrix, not resveratrol specifically. Alcohol itself carries risk.

Should I combine pterostilbene and resveratrol?

Some products combine them. They overlap substantially in mechanism, so the additional benefit is unclear. Most longevity protocols pick one.

Is pterostilbene safer than resveratrol?

Both are generally well tolerated. Pterostilbene has less long-term safety data but has shown one concerning signal (mild LDL elevation at higher doses) not commonly seen with resveratrol.

Which is better for skin aging?

Topical formulations of both have shown some benefit. For oral supplementation aimed at skin, evidence is thin for either compound alone.

Key takeaways

Pterostilbene has dramatically better bioavailability than resveratrol due to its two methoxy groups.
Mechanisms largely overlap: both target SIRT1, AMPK, inflammation, and mitochondrial function.
Resveratrol has more human clinical data; pterostilbene has better pharmacokinetics and preclinical potency.
Neither has proven longevity benefit in humans despite decades of marketing.
A polyphenol-rich diet (berries, grapes, tea, olive oil) delivers a more complex and likely more valuable mix than any isolated supplement.

Start tracking your aging today

Supplement decisions should be based on data, not marketing. The only way to know whether any polyphenol protocol is helping is to measure your actual physiology.

Ready to take control? Download SuperAge and start tracking your biological age alongside any supplement protocol you try.

References

Kapetanovic I. M. et al. — Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats. Cancer Chemotherapy and Pharmacology, 2011.
Riche D. M. et al. — Analysis of safety from a human clinical trial with pterostilbene. Journal of Toxicology, 2013.
McCormack D., McFadden D. — A review of pterostilbene antioxidant activity and disease modification. Oxidative Medicine and Cellular Longevity, 2013.
Baur J. A. et al. — Resveratrol improves health and survival of mice on a high-calorie diet. Nature, 2006.
Akinwumi B. C. et al. — Biological activities of stilbenoids. International Journal of Molecular Sciences, 2018.

Last updated: 2026-04-09. This article is regularly reviewed to ensure accuracy.